Dr. Eugenia Girda, MD
Claim this profileRutgers Cancer Institute of New Jersey
Studies Cancer
Studies Ovarian Cancer
14 reported clinical trials
29 drugs studied
Area of expertise
1Cancer
Stage III
Stage IV
POLE
2Ovarian Cancer
BRCA1 positive
POLE
POLD1
Affiliated Hospitals
Clinical Trials Eugenia Girda, MD is currently running
Niraparib Maintenance Therapy
for Endometrial Cancer
Uterine serous carcinoma (USC) accounts for up to 40% of endometrial cancer-related deaths. Patients with USC share many genomic and clinical characteristics with patients who has serous ovarian cancer. The objective of this study is to evaluate the efficacy of maintenance Niraparib regimen in patients with advanced or platinum sensitive recurrent uterine serous carcinoma. Additionally, the investigators aim to further describe the safety of this regimen. The investigators hypothesize that Niraparib maintenance will be a well-tolerated treatment and show significant response in patients with uterine serous carcinoma.
Recruiting1 award Phase 226 criteria
ADP-A2M4CD8 + Nivolumab
for Ovarian Cancer
This trial tests a treatment using modified immune cells alone or with an immune-boosting drug in patients with recurrent ovarian cancer who have a specific genetic marker. The treatment aims to help the immune system better identify and destroy cancer cells.
Recruiting1 award Phase 221 criteria
More about Eugenia Girda, MD
Clinical Trial Related4 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Eugenia Girda, MD has experience with
- Carboplatin
- Pembrolizumab
- Paclitaxel
- Atezolizumab
- Nivolumab
- Bevacizumab
Breakdown of trials Eugenia Girda, MD has run
Cancer
Ovarian Cancer
Serous Cystadenocarcinoma
Recurrence
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eugenia Girda, MD specialize in?
Eugenia Girda, MD focuses on Cancer and Ovarian Cancer. In particular, much of their work with Cancer has involved Stage III patients, or patients who are Stage IV.
Is Eugenia Girda, MD currently recruiting for clinical trials?
Yes, Eugenia Girda, MD is currently recruiting for 6 clinical trials in New Brunswick New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Eugenia Girda, MD has studied deeply?
Yes, Eugenia Girda, MD has studied treatments such as Carboplatin, Pembrolizumab, Paclitaxel.
What is the best way to schedule an appointment with Eugenia Girda, MD?
Apply for one of the trials that Eugenia Girda, MD is conducting.
What is the office address of Eugenia Girda, MD?
The office of Eugenia Girda, MD is located at: Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey 08903 United States. This is the address for their practice at the Rutgers Cancer Institute of New Jersey.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.